BioMarin 製藥公司
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionDaiwa Securities Group Inc.
Latest Disclosed Ownership26,000 shares
Latest Disclosed Value $ 1,468,740
Daiwa Securities Group Inc. reports 5.35% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On May 13, 2026 - Daiwa Securities Group Inc. filed a 13F-HR form disclosing ownership of 26,000 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $1,468,740 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 24,680 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 5.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,000 1,320 5.35 1,469 146,700.00 0.0042
2026-02-10 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,680 -16,209 -39.64 1 -50.00 0.0047
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,889 529 1.31 2 0.00 0.0075
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,360 7,940 24.49 2 0.00 0.0082
2025-05-13 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,420 9,805 43.36 2 100.00 0.0097
2025-02-07 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 22,615 4,609 25.60 1 0.00 0.0066
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,006 1,185 7.04 1 0.00 0.0058
2024-08-07 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,821 514 3.15 1 0.00 0.0074
2024-05-02 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,307 -3,491 -17.63 1 0.00 0.0080
2024-01-31 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,798 379 1.95 2 0.00 0.0119
2023-11-01 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,419 -329 -1.67 2 0.00 0.0122
2023-07-31 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,748 186 0.95 2 0.00 0.0113
2023-05-02 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,562 -368 -1.85 2 -50.00 0.0132
2023-02-06 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,930 -7,246 -26.66 2 -99.91 0.0158
2022-11-02 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 27,176 7,984 41.60 2,303 44.75 0.0191
2022-08-09 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,192 96 0.50 1,591 8.08 0.0122
2022-04-29 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,096 3,189 20.05 1,472 4.69 0.0068
2022-02-03 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,907 -570 -3.46 1,406 10.36 0.0083
2021-11-05 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,477 1,845 12.61 1,274 4.34 0.0084
2021-08-06 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,632 -630 -4.13 1,221 5.99 0.0082
2021-05-03 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,262 -1,427 -8.55 1,152 -21.31 0.0086
2021-02-04 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,689 5,341 47.07 1,464 69.64 0.0113
2020-11-02 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,348 2,417 27.06 863 14.30 0.0078
2020-08-11 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,931 -10,030 -52.90 755 -52.87 0.0159
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,961 3,770 24.82 1,602 24.86 0.0166
2020-01-31 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,191 -9,229 -37.79 1,283 -22.01 0.0106
2019-11-04 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,420 8,003 48.75 1,645 17.08 0.0139
2019-07-24 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,417 -1,233 -6.99 1,405 -10.34 0.0124
2019-04-26 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,650 933 5.58 1,567 10.12 0.0137
2019-02-05 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,717 9,650 136.55 1,423 107.74 0.0137
2018-11-01 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,067 300 4.43 685 7.54 0.0057
2018-07-30 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,767 0 0.00 637 16.03 0.0050
2018-05-02 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,767 1,567 30.13 549 18.32 0.0044
2018-02-06 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,200 0 0.00 464 -4.13 0.0033
2017-11-02 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,200 250 5.05 484 7.56 0.0033
2017-07-28 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,950 50 1.02 450 4.65 0.0029
2017-05-02 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,900 600 13.95 430 20.79 0.0027
2017-02-01 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,300 500 13.16 356 1.14 0.0023
2017-01-10 2016-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 0 0.00 352 18.92 0.0021
2016-11-04 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 352
2016-07-25 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 0 0.00 296 -5.43 0.0018
2016-05-12 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 200 5.56 313 -16.98 0.0020
2016-02-04 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,600 -8,000 -68.97 377 -69.15 0.0025
2015-11-10 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,600 -1,300 -10.08 1,222 -30.73 0.0087
2015-08-05 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,900 9,100 239.47 1,764 272.15 0.0125
2015-05-12 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 0 0.00 474 37.79 0.0032
2015-02-13 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 -14,233 -78.93 344 -73.56 0.0024
2014-11-12 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,033 -20,608 -53.33 1,301 -45.86 0.0099
2014-08-13 2014-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 38,641 -5,880 2,403 0.0179
2014-08-13 2014-06-30 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 38,641 -5,880 -13.21 2,403 -20.88 0.0518
2014-08-13 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,641 2,403
2014-05-14 2014-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 44,521 40,121 3,037 0.0238
2014-05-15 2014-03-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 44,521 40,121 911.84 3,037 879.68 0.0238
2014-05-13 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 44,521 3,037
2014-02-13 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,400 0 0.00 310 -2.52 0.0026
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,400 600 15.79 318 50.00 0.0025
2013-08-16 2013-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 3,800 212 0.0016
2013-08-13 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,800 212
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.